• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PAF-Wnt信号诱导的细胞可塑性是维持乳腺癌细胞干性所必需的。

PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.

作者信息

Wang Xin, Jung Youn-Sang, Jun Sohee, Lee Sunhye, Wang Wenqi, Schneider Andrea, Sun Oh Young, Lin Steven H, Park Bum-Joon, Chen Junjie, Keyomarsi Khandan, Park Jae-Il

机构信息

Department of Experimental Radiation Oncology, University of Texas MD Anderson Cancer Center, 6565 MD Anderson Boulevard, Z6.6034, Unit 1052, Houston, Texas 77030, USA.

Department of Molecular Biology, Pusan National University, Busan 609-735, Korea.

出版信息

Nat Commun. 2016 Feb 4;7:10633. doi: 10.1038/ncomms10633.

DOI:10.1038/ncomms10633
PMID:26843124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4743006/
Abstract

Cancer stem cells (CSCs) contribute to tumour heterogeneity, therapy resistance and metastasis. However, the regulatory mechanisms of cancer cell stemness remain elusive. Here we identify PCNA-associated factor (PAF) as a key molecule that controls cancer cell stemness. PAF is highly expressed in breast cancer cells but not in mammary epithelial cells (MECs). In MECs, ectopic expression of PAF induces anchorage-independent cell growth and breast CSC marker expression. In mouse models, conditional PAF expression induces mammary ductal hyperplasia. Moreover, PAF expression endows MECs with a self-renewing capacity and cell heterogeneity generation via Wnt signalling. Conversely, ablation of endogenous PAF induces the loss of breast cancer cell stemness. Further cancer drug repurposing approaches reveal that NVP-AUY922 downregulates PAF and decreases breast cancer cell stemness. Our results unveil an unsuspected role of the PAF-Wnt signalling axis in modulating cell plasticity, which is required for the maintenance of breast cancer cell stemness.

摘要

癌症干细胞(CSCs)导致肿瘤异质性、治疗抗性和转移。然而,癌细胞干性的调控机制仍不清楚。在此,我们确定增殖细胞核抗原相关因子(PAF)是控制癌细胞干性的关键分子。PAF在乳腺癌细胞中高表达,但在乳腺上皮细胞(MECs)中不表达。在MECs中,PAF的异位表达诱导不依赖贴壁的细胞生长和乳腺癌干细胞标志物表达。在小鼠模型中,条件性PAF表达诱导乳腺导管增生。此外,PAF表达通过Wnt信号赋予MECs自我更新能力和细胞异质性产生。相反,内源性PAF的缺失导致乳腺癌细胞干性丧失。进一步的癌症药物重新利用方法表明,NVP-AUY922下调PAF并降低乳腺癌细胞干性。我们的结果揭示了PAF-Wnt信号轴在调节细胞可塑性中的意想不到的作用,这是维持乳腺癌细胞干性所必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/772e42204e60/ncomms10633-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/bdf472ca3195/ncomms10633-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/73b5ddadf65e/ncomms10633-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/546391f58fd4/ncomms10633-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/36d050b3faee/ncomms10633-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/9ba439267c6c/ncomms10633-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/393257ed96e5/ncomms10633-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/772e42204e60/ncomms10633-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/bdf472ca3195/ncomms10633-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/73b5ddadf65e/ncomms10633-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/546391f58fd4/ncomms10633-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/36d050b3faee/ncomms10633-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/9ba439267c6c/ncomms10633-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/393257ed96e5/ncomms10633-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8523/4743006/772e42204e60/ncomms10633-f7.jpg

相似文献

1
PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness.PAF-Wnt信号诱导的细胞可塑性是维持乳腺癌细胞干性所必需的。
Nat Commun. 2016 Feb 4;7:10633. doi: 10.1038/ncomms10633.
2
PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis.PAF-Myc 调控的细胞干性对于肠道再生和肿瘤发生是必需的。
Dev Cell. 2018 Mar 12;44(5):582-596.e4. doi: 10.1016/j.devcel.2018.02.010.
3
Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.Mel-18 的缺失通过 Wnt/TCF 通路激活 Notch 信号,增强乳腺癌干细胞的活性和致瘤性。
FASEB J. 2012 Dec;26(12):5002-13. doi: 10.1096/fj.12-209247. Epub 2012 Sep 5.
4
Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.正常和癌性乳腺干细胞通过miR-199a-LCOR轴逃避干扰素诱导的限制。
Nat Cell Biol. 2017 Jun;19(6):711-723. doi: 10.1038/ncb3533. Epub 2017 May 22.
5
Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ERα Mammary Carcinomas.抗雌激素治疗增加了催乳素诱导的 ERα 乳腺癌的可塑性和癌症干性。
Cancer Res. 2018 Apr 1;78(7):1672-1684. doi: 10.1158/0008-5472.CAN-17-0985. Epub 2018 Jan 23.
6
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance.HOXD3在乳腺癌干性和耐药性中起关键作用。
Cell Physiol Biochem. 2018;46(4):1737-1747. doi: 10.1159/000489249. Epub 2018 Apr 23.
7
Wnt pathway activity in breast cancer sub-types and stem-like cells.Wnt 通路在乳腺癌亚型和干细胞样细胞中的活性。
PLoS One. 2013 Jul 4;8(7):e67811. doi: 10.1371/journal.pone.0067811. Print 2013.
8
The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling.SC RB 蛋白类似物 LANO/LRRC1 通过 WNT/β-连环蛋白信号通路调控乳腺癌干细胞命运。
Stem Cell Reports. 2018 Nov 13;11(5):1040-1050. doi: 10.1016/j.stemcr.2018.09.008. Epub 2018 Oct 18.
9
The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.刺猬信号通路介导乳腺癌患者MCF-7乳腺球细胞的药物反应。
Clin Sci (Lond). 2015 Nov;129(9):809-22. doi: 10.1042/CS20140592. Epub 2015 Jul 2.
10
MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.微小RNA-1通过抑制Wnt/β-连环蛋白信号通路下调乳腺癌干细胞的增殖和迁移。
Oncotarget. 2015 Dec 8;6(39):41638-49. doi: 10.18632/oncotarget.5873.

引用本文的文献

1
Knockdown of BAP31 Suppresses Tumorigenesis and Stemness in Breast Cancer Cells via the Hippo Pathway.敲低BAP31通过Hippo信号通路抑制乳腺癌细胞的肿瘤发生和干性
Int J Mol Sci. 2025 Apr 10;26(8):3576. doi: 10.3390/ijms26083576.
2
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance.解析缺氧、癌细胞干性和耐药性三者之间的关系。
J Hematol Oncol. 2025 Mar 18;18(1):32. doi: 10.1186/s13045-025-01684-4.
3
Recombinant α-Toxin BmK-M9 Inhibits Breast Cancer Progression by Regulating β-Catenin In Vivo.重组α-毒素BmK-M9通过在体内调节β-连环蛋白抑制乳腺癌进展。

本文引用的文献

1
PAF-mediated MAPK signaling hyperactivation via LAMTOR3 induces pancreatic tumorigenesis.血小板活化因子(PAF)通过LAMTOR3介导的丝裂原活化蛋白激酶(MAPK)信号过度激活诱导胰腺肿瘤发生。
Cell Rep. 2013 Oct 31;5(2):314-22. doi: 10.1016/j.celrep.2013.09.026.
2
PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation.PAF 和 EZH2 诱导 Wnt/β-catenin 信号通路过度激活。
Mol Cell. 2013 Oct 24;52(2):193-205. doi: 10.1016/j.molcel.2013.08.028. Epub 2013 Sep 19.
3
A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway.
Cell Biochem Biophys. 2025 Mar 13. doi: 10.1007/s12013-025-01711-8.
4
Regulation of the β‑catenin/LEF‑1 pathway by the siRNA knockdown of RUVBL1 expression inhibits breast cancer cell proliferation, migration and invasion.通过小干扰RNA敲低RUVBL1表达对β-连环蛋白/淋巴细胞增强因子1信号通路的调控可抑制乳腺癌细胞的增殖、迁移和侵袭。
Oncol Rep. 2025 Feb;53(2). doi: 10.3892/or.2024.8855. Epub 2024 Dec 13.
5
Integration of single-cell sequencing and bulk transcriptome data develops prognostic markers based on PCLAF stem-like tumor cells using artificial neural network in gastric cancer.整合单细胞测序和批量转录组数据,利用人工神经网络在胃癌中基于PCLAF干细胞样肿瘤细胞开发预后标志物。
Heliyon. 2024 Sep 29;10(21):e38662. doi: 10.1016/j.heliyon.2024.e38662. eCollection 2024 Nov 15.
6
PCLAF-DREAM drives alveolar cell plasticity for lung regeneration.PCLAF-DREAM 驱动肺泡细胞可塑性实现肺再生。
Nat Commun. 2024 Oct 24;15(1):9169. doi: 10.1038/s41467-024-53330-1.
7
The therapeutic effect of traditional Chinese medicine on breast cancer through modulation of the Wnt/β-catenin signaling pathway.中药通过调节Wnt/β-连环蛋白信号通路对乳腺癌的治疗作用。
Front Pharmacol. 2024 May 9;15:1401979. doi: 10.3389/fphar.2024.1401979. eCollection 2024.
8
Signaling, cancer cell plasticity, and intratumor heterogeneity.信号转导、癌细胞可塑性和肿瘤内异质性。
Cell Commun Signal. 2024 May 3;22(1):255. doi: 10.1186/s12964-024-01643-5.
9
A structure-based designed small molecule depletes hRpn13 and a select group of KEN box proteins.基于结构设计的小分子耗尽 hRpn13 和一组选择的 KEN 盒蛋白。
Nat Commun. 2024 Mar 20;15(1):2485. doi: 10.1038/s41467-024-46644-7.
10
Stem Cell Protein PIWIL2 Promotes EMT Process and Stem Cell-Like Properties in MCF7 Breast Cancer Cell Line.干细胞蛋白PIWIL2促进MCF7乳腺癌细胞系中的上皮-间质转化过程及干细胞样特性。
Adv Biomed Res. 2023 Nov 29;12:250. doi: 10.4103/abr.abr_115_23. eCollection 2023.
基质金属蛋白酶通过 Wnt 信号通路在调节乳腺干细胞功能中的作用。
Cell Stem Cell. 2013 Sep 5;13(3):300-13. doi: 10.1016/j.stem.2013.06.005. Epub 2013 Jul 18.
4
Intestinal label-retaining cells are secretory precursors expressing Lgr5.肠干细胞是分泌前体细胞,表达 Lgr5。
Nature. 2013 Mar 7;495(7439):65-9. doi: 10.1038/nature11965. Epub 2013 Feb 27.
5
Delineation of breast cancer cell hierarchy identifies the subset responsible for dormancy.乳腺癌细胞层级划分鉴定出休眠亚群。
Sci Rep. 2012;2:906. doi: 10.1038/srep00906. Epub 2012 Nov 30.
6
Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass.系统范围的泛素化动力学分析揭示了 PAF15 泛素化在 DNA 损伤绕过中的关键作用。
Nat Cell Biol. 2012 Oct;14(10):1089-98. doi: 10.1038/ncb2579. Epub 2012 Sep 23.
7
Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland.发育阶段和时间决定了乳腺中 Wnt/β-连环蛋白反应性干细胞的命运。
Cell Stem Cell. 2012 Sep 7;11(3):387-400. doi: 10.1016/j.stem.2012.05.023. Epub 2012 Aug 2.
8
Wnt/β-catenin signaling and disease.Wnt/β-连环蛋白信号通路与疾病
Cell. 2012 Jun 8;149(6):1192-205. doi: 10.1016/j.cell.2012.05.012.
9
Cancer stem cells: impact, heterogeneity, and uncertainty.癌症干细胞:影响、异质性和不确定性。
Cancer Cell. 2012 Mar 20;21(3):283-96. doi: 10.1016/j.ccr.2012.03.003.
10
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells.随机状态转变导致癌细胞群体中的表型平衡。
Cell. 2011 Aug 19;146(4):633-44. doi: 10.1016/j.cell.2011.07.026.